CHRONIC
KIDNEY
DISEASE
Chair: Steve Smith, Birmingham Heartlands Hospital, President BRS
O1 Variability in referral patterns to renal services in Kent
H J Hobbs, Kent and Canterbury Hospital
O2 Risk of CKD progression and
mortality related to renal function in patients aged 61-65 years
MW Taal, Derby City General Hospital
O3 Recognition of a large cohort of CKD patients in West Lincolnshire by a
primary care-based disease management programme (DMP)
NT Richards, Tipton Dialysis Unit, Brimingham
O4 Area deprivation predicts development of CKD in the population
AK Bello, Sheffield Kidney Institute
O5 A
systematic Diabetic Renal Service – better for patients and clinicians
HC Rayner, Birmingham Hearlands Hospital
O6 The value of routine renal ultrasound (US) in patients with CKD
KPG Harris, Leicester General Hospital
O7 A
longitudinal study of extracellular fluid in patients with CKD
LM Wells, York Hospital
O8 Outcomes in CKD : Prognostic
role of ischaemia and subclinical left venticular abnormalities and
impact of transplantation
DJ Rakhit, University of Queensland, Brisbane, Australia
|
LABORATORY
SCIENCE:
CELL COMMUNICATION
Chair: Jeremy Hughes, University of Edinburgh School of Medicine
Cross-talk between
glomerular cells.
Guest Speaker:
Moin Saleem, Reader in
Paediatric Nephrology, University of Bristol
O9 VEGF165b
defines the phenotype of the normal glomerulus
SJ
Harper, University of Bristol
O10 Interferon Beta attenuates proteinuria in 3 models of experimental
glomerular injury and modulates barrier properties of human glomerular
endothelial cells and podocytes in culture
S C
Satchell, University of Bristol
O11 The
differential role of Ras Isoforms in TGFß1 induced connective tissue
growth factor expression in human proximal tubule epithelial cells
MK Phanish, SW Thames Institute for Renal Research, Carshalton
O12 The
hyperproliferation of PKD1 cystic cells to insulin-like growth factor-1
and cAMmP is medicated by a Ras/Raf dependent signalling pathway
E Parker, Sheffield Kidney Institute
O13 Toll-like receptor 4 is required on both bone marrow derived and non-bone
marrow derived cells for maximal neutrophil influx in heterologous
neprhotoxic nephritis
HJ Brown, King’s College London School of Medicine
O14 Investigating the role of tumour necrosis factor alpha in graft rejection
across a minor (hy) mismatch skin transplantation model
PE Herbert, Imperial College London |
TRANSPLANT
FORUM
Sponsored by: Novartis
Chair: Phil Dyer, Manchester Royal Infirmary
The impact of 3 initiatives for improving donation rates in the UK.
Guest Speaker: Lisa Burnapp,
Nurse Consultant, Living Transplantation, Guy’s and St Thomas’s Hospital
Trust, London
O15 Randomised
controlled trial of open versus laparoscopic live donor nephrectomy
ML Nicholson, University Hospitals of Leicester
O16 Outcome of renal
transplantation in 300 children between 1973 and 2000
R Shroff, Great Ormand Street Hospital for Children NHS Trust,
London
O17 Antibody
incompatible transplantation – demand and outcomes
RM Higgins, Coventry and Warwickshire NHS Trust
O18 ABO
incompatible live donor transplantation with Rituximab
JW Galliford, West London Renal Transplant Centre, Hammersmith
O19 Vitamin D status in long-term renal transplant recipients
AS Stavroulopoulos, Nottingham City Hospital NHS Trust
O20 Early neural
regeneration after pancreas transplantation detected by corneal confocal
microscopy: A pilot study
S Mehra,
Manchester Royal Infirmary |
EXERCISE AND
FRAILTY
Chair:
Tom Mercer, Queen Mary University College, Edinburgh
The epidemiology of muscle wasting and weakness in renal failure.
Guest Speaker: Patrick Naish,
Consultant Nephrologist, North Staffordshire Infirmary
O21 The Acidosis-Sensing amino
acid pump SNAT2 determines intracellular levels of the anabolic amino acids
L-Gln and L-Leu in Skeletal Muscle Cells
A Bevington, Leicester General Hospital
O22 Functionally significant progressive skeletal muscle wasting in CKD4 and
CKD5 (PD and HD) patients
CW McIntyre, Derby City General Hospital
O23 Can a
Structured, Multidisciplinary Programme Combining Exercise, Diet and
Orlistat Achieve Significant Weight Loss and Improved Functional Ability in
Patients with CKD ?
S A Cook, Kings College Hospital,
London
024 Effects of a 12 month
training programme on quality of life, functional ability and nutritional
status in long term HD patients
S Smith, Queen Margaret University College, Edinburgh
Towards exercise as part of routine care for
chronic kidney disease.
Guest Speaker: Jamie MacDonald,
Exercise
Physiologist, University of Bangor, Wales
|
